Real-time enrollment status for this crohn's disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 5:15 AM UTC
| NCT Number | NCT06226883 |
| Recruiting Status | Recruiting |
| Condition | Crohn's Disease |
| Phase | PHASE2 |
| Target Enrollment | 385 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06226883 is currently recruiting participants. This phase2 study for crohn's disease is actively seeking new participants at 25 locations across the United States. The study is sponsored by Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06226883 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06226883 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.